/Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026
NEWS
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026
EMA
2026/04/07Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026
Date
Tuesday, 07 April
Friday, 10 April 2026
,
All day
Location
European Medicines Agency, Amsterdam, the Netherlands
Event summary
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
Documents
Agenda of the PRAC meeting 7-10 April 2026
Draft
Reference Number:
EMA/PRAC/68437/2026
English (EN) (478.02 KB - PDF)
First published:
07/04/2026
View
Related content
Summary
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026